EV-077 + Placebo
Phase 2Terminated 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes
Conditions
Type 2 Diabetes
Trial Timeline
Jan 1, 2012 → May 1, 2012
NCT ID
NCT01551381About EV-077 + Placebo
EV-077 + Placebo is a phase 2 stage product being developed by Evolva Holding SA for Type 2 Diabetes. The current trial status is terminated. This product is registered under clinical trial identifier NCT01551381. Target conditions include Type 2 Diabetes.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01551381 | Phase 2 | Terminated |
Competing Products
20 competing products in Type 2 Diabetes